Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that results in severe cognitive decline. Amyloid plaques are a principal pathology found in AD and are composed of aggregated amyloid-beta (Aß) peptides. According to the amyloid hypothesis, Aß peptides initiate the other pathologies characteristic for Alzheimer's disease including cognitive deficits. Immunotherapy against Aß is a potential therapeutic for the treatment of humans with AD. While anti-Aß immunotherapy has been shown to reduce amyloid burden in mouse models and now in humans, immunotherapy also exacerbates vascular pathologies. Cerebral amyloid angiopathy (CAA), that is, the accumulation of amyloid in the cerebrovasculature, is increased with immunotherapy in humans with AD and in mouse models of amyloid deposition. CAA persists in the brains of clinical trial patients that show removal of parenchymal amyloid. Mouse model studies also show that immunotherapy results in multiple small bleeds in the brain, termed microhemorrhages. The neurovascular unit is a term used to describe the cerebrovasculature and its associated cellsastrocytes, neurons, pericytes and microglia. CAA affects brain perfusion and there is now evidence that the neurovascular unit is affected in Alzheimer's disease when CAA is present. Understanding the type of damage to the neurovascular unit caused by CAA in AD and the underlying cause of microhemorrhage after immunotherapy is essential to the success of therapeutic vaccines as a treatment for Alzheimer's disease.
The neurovascular unitThe brain's high energy demands require a disproportionate blood supply. While the brain only composes 2% of the total body weight, it receives 15% of the cardiac output and consumes 20% of the oxygen utilized by the entire body. Maintenance and control of this blood supply requires communication between multiple components of the brain and cerebrovasculature. The cellular interface between the parenchyma of the brain and the circulating blood is composed of the blood vessel itself, perivascular neurons, pericytes, perivascular microglia and astrocytic end-feet and has been termed the neurovascular unit (NVU) 1 . The vascular component of the NVU includes the penetrating arteries that arise from the pial arteries on the surface of the brain, the arterioles and cerebral capillaries. Figure 1 summarizes the structures of the NVU. The larger arteries are composed of an endothelial layer, a smooth muscle layer and the adventitia composed of collagen, fibroblasts and perivascular nerves. Virchow-Robin spaces are CSF-filled spaces that separate the penetrating vessel from the brain. Astrocytic end-feet are located on the brain side of this space and impinge upon the pia mater that separates the fluid filled space from the adventitia of the blood vessel 2 . As the arteries branch and become smaller arterioles, the Virchow-Robin spaces shrink and disappear. At this point the astrocytic end-feet directly attach to the basement membrane of the vasculature 3 . The arterioles lose...